Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil liposome injection in lower extremity arteriosclerosis obliterans
CTR20191908Phase 2Active
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in arteriosclerosis obliterans, sponsored by CSPC Pharmaceutical Group. Started Sep 2019; status: active.
02
Drugs
Vasostenoon
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on CTR20191908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191908.